2024 was a transformative year for Takis!
A standout was the opening of our new BSL-3 Facility, boosting our research capabilities. We’ve also made significant strides in monoclonal antibody production, with scaling techniques showcased at key venues like I4ID2024 in Lyon. Takis was also selected for the IPCEI “Med4Cure” project, focusing on vaccines and gene therapies, including developing treatments for COVID-19 and […]